A5083473990- Multiple and Secondary Primary Cancers
- Lung Cancer Treatments and Mutations
- Lymphoma Diagnosis and Treatment
- Economic and Financial Impacts of Cancer
- Mesenchymal stem cell research
- Tissue Engineering and Regenerative Medicine
- Chronic Lymphocytic Leukemia Research
- Esophageal Cancer Research and Treatment
- Uterine Myomas and Treatments
- Acute Lymphoblastic Leukemia research
- Palliative Care and End-of-Life Issues
- Global Cancer Incidence and Screening
- Pluripotent Stem Cells Research
- Pancreatic and Hepatic Oncology Research
- Genetic factors in colorectal cancer
- Neuroblastoma Research and Treatments
- Childhood Cancer Survivors' Quality of Life
- Endometriosis Research and Treatment
- Nuclear Receptors and Signaling
- 14-3-3 protein interactions
- Diabetes Management and Research
- Electrospun Nanofibers in Biomedical Applications
- Lung Cancer Research Studies
- Neuroendocrine Tumor Research Advances
- Esophageal and GI Pathology
University of Arkansas for Medical Sciences
2023-2024
Rogers (United States)
2023-2024
Caribbean Research and Management of Biodiversity Foundation
2021-2023
Esophageal malignancies, constituting 3% of global cancers, pose significant health challenges with poor survival rates. Squamous Cell Carcinoma (SCC) and Adenocarcinoma (AC) are predominant subtypes, shifting incidences globally. This analysis will focus primarily on the demographics trends for cell carcinoma esophagus (SCCE). retrospective study, utilizing SEER database, examined demographic factors influencing in SCC upper esophagus. Variables included age, sex, race, income, rurality....
Patients presenting with large cell neuroendocrine carcinomas (LCNECs) comprise a small minority of total colon and rectal cancers (1-2%) poor prognostic outcomes in lieu late diagnosis metastasis at the point diagnosis.
e24066 Background: Lung, colorectal, pancreatic, breast & prostate cancer account for the top 5 malignancies resulting in mortality US. The need palliative care patients with these continues to grow monitoring its utilization is crucial, especially among different racial groups ethnicities. Methods: In this study, TriNetX database which a collaboration between; pharmaceutical companies, research organizations HCOs was used. A total of 3,221,731 de-identified pts (pediatric, AYA adult)...
e18526 Background: Myelodysplastic syndromes (MDS) are a group of hemopoietic disorders in which the bone marrow is deficient producing healthy mature blood cells. MDS associated with deletion long arm chromosome 5Q rare occurrence, but considered good prognosis comparison to other subgroups MDS. There has been limited focus directed towards this variant disease, especially concerning outcomes among different demographics. Methods: The National Cancer Institute’s Surveillance, Epidemiology,...
Background: B-cell prolymphocytic leukemia (B-PLL) is a rare disease, consisting <1% of mature malignancies. B-PLL often refractory to chemotherapy, with median survival 3 years. Due its rarity, no large cohort studies exist elucidating outcomes. Methods: All patients >15 years were identified in the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database between 2000-2020. Statistical analysis explored demographic variables like age; categorized as...